26 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter.
21 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) rose 95.5% to $2.19 in pre-market trading after surging 43% on Tuesday.
FDA Website Shows Dec. 22-Dated update On Antigen Tests For Omicron: ‘The FDA continues to monitor and evaluate the impact of genetic variants on antigen tests…’
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-covid-19-tests?utm_medium=email&utm_source=govdelivery#omicronvariantimpact
FDA Asks Chembio Additional Data On HIV-Syphilis Test For CLIA Waiver
Chembio Diagnostics Inc's (NASDAQ: CEMI) said that on December 1, it received an FDA notice for additional data related to Clinical Laboratory Improvement Amendment (CLIA) waiver submission for the DPP HIV-Syphilis test system.
Chembio Diagnostics Says O Dec. 1 Received Notice From FDA That FDA Would Require Additional Data Related To Clinical Laboratory Improvement Amendment Waiver Submission For DPP HIV-Syphilis Test System
Request for Additional Data Related to CLIA Waiver Submission for DPP HIV-Syphilis Test System
On December 1, 2021, we received notice from the U.S. Food and Drug Administration, or FDA, that the FDA
Chembio Diagnostics Submits FDA De Novo/510(k) Request For DPP SARS-CoV-2 Antigen Test System
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has submitted a De Novo/510(k) Request to the U.S. Food and Drug
Chembio Diagnostics’ DPP COVID-19 Antigen Test Approved In South Africa
South Africa Health Products Regulatory Authority (SAHPRA) has approved Chembio Diagnostics Inc's (NASDAQ: CEMI) DPP SARS-CoV-2 Antigen test for use at the point of care.
Chembio Files For FDA Emergency Use Nod For COVID-19 Antigen Test
Chembio Diagnostics Inc (NASDAQ:CEMI) submitted an Emergency Use Authorization (EUA) application to the FDA for the new DPP SARS-CoV-2 Antigen test.…
